论文部分内容阅读
目的:探讨逍遥散加味联合西药治疗卒中后抑郁(PSD)的临床疗效。方法:选择北京市门头沟区中医医院2016年12月至2017年2月脑病科收治的PSD患者44例,随机分为治疗组与对照组,各22例。治疗组应用逍遥散加味及氢溴酸西酞普兰片,对照组应用氢溴酸西酞普兰片,观察评价两组的治疗效果。结果:经治疗,治疗组的总有效率为95.5%,明显高于对照组的86.4%,差异有统计学意义(P<0.05)。结论:逍遥散加味联合西酞普兰片对PSD肝郁脾虚型疗效显著。
Objective: To investigate the clinical efficacy of Xiaoyaosan flavored with western medicine in the treatment of post-stroke depression (PSD). Methods: Forty-four PSD patients admitted to Mentougou District Chinese Medicine Hospital in Beijing from December 2016 to February 2017 were randomly divided into treatment group and control group, with 22 cases in each group. The treatment group was treated with Xiaoyaosan flavored and citalopram hydrobromide tablets, and the control group was treated with citalopram hydrobromide tablets. The therapeutic effects of the two groups were observed and evaluated. Results: After treatment, the total effective rate of the treatment group was 95.5%, which was significantly higher than that of the control group (86.4%), the difference was statistically significant (P <0.05). Conclusion: Xiaoyao San flavored joint citalopram tablet has a significant effect on PSD with liver depression and spleen deficiency syndrome.